🔴 This is an archived resource.

This resource has not been reviewed within the last three years to reflect up to date clinical guidelines and should be referenced with care.

Position statement on the use of sodium-glucose cotransporter-2 inhibitors in type 1 diabetes (updated 2019)

Position statement on use of SGLT-2 inhibitors in tpe 1 diabetes

Discipline

Diabetes
Resource taxonomy
Position Paper
Clinical taxonomy
Treatments for diabetes
Listing status
Archived
Published
2019